drugset / Trial / NCT04688645

Balanced Crystalloid Solutions for Acute Pancreatitis

NCT04688645

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Patients diagnosed with acute pancreatitis regardless of etiology, severity of disease, and prior attacks will be randomized in two groups. The intervention group will receive a balanced crystalloid (Plasmalyte) at a rate of 10 ml/kg during the first 60 min and then continued at 3 ml/kg/h for the next 72 hours. The control group will receive normal saline at the same rate.

Timeline

Start
2020-05-01
Primary completion
2022-12-01
Completion
2023-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator 0.9% sodium chloride solution Unknown 2 unknown
Subject Plasmalyte Other / unclassified 2 unknown

Indications